Daily vs alternate oral iron therapy in pregnant women in iron deficiency anaemia

Daily versus intermittent oral iron therapy in pregnant women with iron deficiency anaemia: A single centre, open label, non-randomized control trial.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/07/035271

Enrollment

124

Registered

2021-07-29

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O280- Abnormal hematological finding onantenatal screening of mother

Interventions

Intervention1: Daily versus intermittent oral iron therapy in pregnant women with iron deficiency anaemia: Group 1-(twice daily arm) Tablet ferrous fumarate 1 tablet containing 50 mg elemental iro

Eligibility

Inclusion criteria

Inclusion criteria: Pregnant women with haemoglobin concentration less than 11 g/dL and haematocrit less than 33% with singleton pregnancy between 16-28 weeks of gestation, irrespective of parity will be taken

Exclusion criteria

Exclusion criteria: • Multiple pregnancy • underweight (BMI 30kg/m2) • Severe anemia with maternal hemoglobin levels less than 7 g/dL • Hypertensive disorders of pregnancy • Diabetes mellitus (gestational /overt ) not controlled on diet • Anaemia of chronic disease • History of gastrointestinal bleeding • Haemoglobinopathies • Megaloblastic anaemia • HIV, HBsAg, HCV, Covid-19 positive

Design outcomes

Primary

Measure	Time frame
response to therapy Following blood tests will be done as baseline ,3-week ,6 week interval â?¢ Complete blood count â?¢ Total iron study Timepoint: response to therapy Following blood tests will be done as baseline ,3-week ,6 week interval â?¢ Complete blood count â?¢ Total iron study	—

Secondary

Measure	Time frame
Side effects,complianceTimepoint: 3 week,6 week	—

Countries

India

Contacts

Public ContactJyotsna Pathak

Indira Gandhi Institute of Medical Sciences,Patna,Bihar,India

jyotsnapathak2010@gmail.com7004128759

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026